Preclinical and Clinical Data on Extraglycemic Effects of GLP-1 Receptor Agonists
{{output}}
The diverse actions of the incretin hormone glucagon-like peptide (GLP)-1 include insulinotropic, beta-cell preservative, cardioprotective and vasodilatory effects. This spectrum makes GLP-1 an appealing therapeutic option for patients with type 2 diabetes. Ho... ...
